EVALUATION OF THE EFFICACY OF ASSISTED REPRODUCTIVE TECHNOLOGIES IN POLYCYSTIC OVARIAN SYNDROME
G.A. IkhtiyarovaBukhara State Medical InstituteМузаффарова, Мухиба ХамзаевнаBukhara State Medical InstituteД.С. ИргашевBukhara State Medical Institute
2022en
Ochiq kirishOlmos
Litsenziya: cc-by
ABI
Annotatsiya
Authors did genetic tests have been carried outgene polymorphism studies CYP17A1(rs743572)106 patients with PCOS. The results of the study showed that the mutant form (AA) of the CYP17A1 rs743572 gene, this risk of PCOS in patients without metabolic syndrome, but this risk is not significant. The CY17A1 polymorphism in patients with PCOS can be said that the GG mutant genotype was statistically significantly more common in the observed patients compared to the control group.
Hali tarjima qilinmagan
Iqtiboslar va manbalar
0 ta iqtibos0 ta foydalanilgan manba